Navigation Links
Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities

BATESVILLE, Ind., June 24 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC) today announced the signing of a distribution agreement with Tri-anim Health System, Inc. (Sylmar, Calif.). The agreement will enhance selling efforts for Hill-Rom's product The Vest(R) Airway Clearance System to both acute and long-term care facilities within the United States.

"We are excited to move forward partnering with Tri-anim," said Kim Dennis, group vice president, Post Acute Care at Hill-Rom. "We believe this strategic alliance will enhance our focus on increasing awareness of the importance of Airway Clearance Therapy in the treatment of respiratory conditions across the care continuum."

Dennis added that, "Hill-Rom's expertise in providing innovative medical technology products, such as The Vest System, will fit well with Tri-anim's experience as the nation's largest specialty distributor of respiratory care products in the acute care segment. This relationship will be good for patients and their caregivers, and will enhance the goals of both our companies."

"We are thrilled to have the opportunity to represent such a respected and recognized brand in the healthcare market and look forward to taking Hill-Rom's The Vest Airway Clearance System into the Acute Care Market," said Bob Byers, Jr., president and founder of Tri-anim. "The Vest System has been clinically proven as an effective device in the treatment of retained pulmonary secretions for over 15 years. We are confident that the specialty distribution partnership between Tri-anim and Hill-Rom will lead to greater application of the High Frequency Chest Wall Oscillation technology in all areas of the hospital to help reduce pulmonary complications and improve patient outcomes."

The Vest Airway Clearance System, Model 205, which in 2007 received a Medical Design Excellence Award(R) for distinction in engineering and design, will be the first product to be distributed with Tri-anim.

The Vest System uses High-Frequency Chest Wall Oscillation (HFCWO) technology to provide both the patient and clinician with a safe, easy to use, and effective method of Airway Clearance Therapy. HFCWO therapy is prescribed for patients with retained secretions as a result of either acute or chronic respiratory conditions.


For more than 30 years, Tri-anim has met the needs and exceeded the expectations of providers throughout the healthcare continuum, including hospitals, emergency medical services (EMS), long-term care facilities, surgery centers and nursing homes. Tri-anim is an industry leader providing e-commerce solutions enabling customers a faster and more efficient procurement method for purchasing medical products. The e-Quick(R) System, a proprietary patent-pending technology, allows customers to place a five-line order in less than 45 seconds. All in-stock orders received - until 5 p.m. - are shipped the same day from one of 13 distribution centers nationwide. For more information, go to


Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and workflow information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.
Hill-Rom...enhancing outcomes for patients and their caregivers.

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward- looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward- looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the recent spin-off of the funeral service business, failure to realize the anticipated benefits of the spin-off, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2007, its Current Report on Form 8-K filed with the SEC on March 17, 2008, and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. The Company assumes no obligation to update or revise any forward- looking statements.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hill-Rom to Present at the Jefferies Healthcare Conference
2. Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
3. Hill-Rom Announces Third Quarter 2008 Dividend
4. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
5. Hill-Rom to Present at the Citi Healthcare Conference
6. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
7. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
8. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
9. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
10. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
11. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: